Home LiteratureArticle Details
PMID: 22661955 Published · epublish English Journal Article

Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles.

Frontiers in physiology ·Vol. 3 ·2012-00-00 ·Pages 162

Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J, Kuo WP

Abstract

Microvesicles are nano-sized lipid vesicles released by all cells in vivo and in vitro. They are released physiologically under normal conditions but their rate of release is higher under pathological conditions such as tumors. Once released they end up in the systemic circulation and have been found and characterized in all biofluids such as plasma, serum, cerebrospinal fluid, breast milk, ascites, and urine. Microvesicles represent the status of the donor cell they are released from and they are currently under intense investigation as a potential source for disease biomarkers. Currently, the "gold standard" for isolating microvesicles is ultracentrifugation, although alternative techniques such as affinity purification have been explored. Viscosity is the resistance of a fluid to a deforming force by either shear or tensile stress. The different chemical and molecular compositions of biofluids have an effect on its viscosity and this could affect movements of the particles inside the fluid. In this manuscript we addressed the issue of whether viscosity has an effect on sedimentation efficiency of microvesicles using ultracentrifugation. We used different biofluids and spiked them with polystyrene beads and assessed their recovery using the Nanoparticle Tracking Analysis. We demonstrate that MVs recovery inversely correlates with viscosity and as a result, sample dilutions should be considered prior to ultracentrifugation when processing any biofluids.

Keywords
biofluids micovesicles sedimentation efficiency size ultracentrifugation viscosity
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Momen-Heravi Fatemeh
Harvard Catalyst Laboratory for Innovative Translational Technologies, Harvard Medical School Boston, MA, USA.
Balaj Leonora
Alian Sara
Trachtenberg Alexander J
Hochberg Fred H
Skog Johan
Kuo Winston Patrick
References (26)
26 references, click to expand
  1. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.
    Nat Cell Biol. 2008 Dec;10(12):1470-6 PMID: 19011622
  2. Exosomes: from biogenesis and secretion to biological function.
    Immunol Lett. 2006 Nov 15;107(2):102-8 PMID: 17067686
  3. Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk.
    J Cardiovasc Transl Res. 2011 Dec;4(6):811-22 PMID: 21786187
  4. Postprandial changes in plasma and serum viscosity and plasma lipids and lipoproteins after an acute test meal.
    Am J Clin Nutr. 1997 Jan;65(1):36-40 PMID: 8988910
  5. Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs.
    Biochem Biophys Res Commun. 2010 May 28;396(2):528-33 PMID: 20434431
  6. Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process.
    Int J Nanomedicine. 2011;6:2737-48 PMID: 22128248
  7. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Thromb Haemost. 2011 Mar;105(3):396-408 PMID: 21174005
  8. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
    Cancer Res. 2011 Aug 1;71(15):5346-56 PMID: 21670082
  9. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells.
    Mol Cancer. 2011 Sep 22;10:117 PMID: 21939504
  10. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.
    Nat Commun. 2011 Feb 01;2:180 PMID: 21285958
  11. Membrane vesicles as conveyors of immune responses.
    Nat Rev Immunol. 2009 Aug;9(8):581-93 PMID: 19498381
  12. Methodology for isolation, identification and characterization of microvesicles in peripheral blood.
    J Immunol Methods. 2012 Jan 31;375(1-2):207-14 PMID: 22075275
  13. Detection of low density lipoprotein particle fusion by proton nuclear magnetic resonance spectroscopy.
    J Lipid Res. 1998 Aug;39(8):1705-12 PMID: 9717732
  14. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
    Methods. 2012 Feb;56(2):293-304 PMID: 22285593
  15. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis.
    Blood. 1984 Jul;64(1):177-84 PMID: 6733271
  16. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading.
    PLoS One. 2011;6(9):e24234 PMID: 21915303
  17. Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics.
    Biomed Microdevices. 2012 Aug;14(4):641-9 PMID: 22391880
  18. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.
    Cancer Res. 2009 Jul 1;69(13):5601-9 PMID: 19549916
  19. Microvesicles and vesicles of multivesicular bodies versus "virus-like" particles.
    J Natl Cancer Inst. 1975 May;54(5):1137-48 PMID: 165305
  20. Microvesicles: mediators of extracellular communication during cancer progression.
    J Cell Sci. 2010 May 15;123(Pt 10):1603-11 PMID: 20445011
  21. Deterioration of rat-liver mitochondria during centrifugation in a sucrose gradient.
    Eur J Biochem. 1971 Sep 13;22(1):31-9 PMID: 4329218
  22. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.
    AIDS Res Hum Retroviruses. 2011 Feb;27(2):167-78 PMID: 20964480
  23. Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis.
    Lab Invest. 1987 Mar;56(3):264-72 PMID: 3821067
  24. SERUM HYPERVISCOSITY SYNDROME.
    JAMA. 1965 May 10;192:464-7 PMID: 14284847
  25. Exosome isolation for proteomic analyses and RNA profiling.
    Methods Mol Biol. 2011;728:235-46 PMID: 21468952
  26. Body fluid derived exosomes as a novel template for clinical diagnostics.
    J Transl Med. 2011 Jun 08;9:86 PMID: 21651777
Article Info
Journal
Frontiers in physiology
Abbr.
Front Physiol
ISSN
1664-042X
Published
2012-00-00
Epub
2012-00-28
Pages
162
Language
English
Region
Switzerland
NLM ID
101549006
PMCID
PMC3362089
Grants
NCRR NIH HHS · UL1 RR025758 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com